Quality evidence is needed to support a new Medicare Part D medication therapy management (MTM) program performance measure, prompting a scoping review on MTM services and associated outcomes.
Jennifer M. Bingham, PharmD, BCACP
Advertisement
Articles by Jennifer M. Bingham, PharmD, BCACP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
2
FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance
3
SGLT2 Inhibitors Tied to Lower Platelet Activation in HFrEF
4
Respiratory Biologics Linked to Reduced Asthma Exacerbations Across Patient Groups
5